Header Logo
Last Name

Dr Samson Kinyanjui

TitleHead of Training and Capacity Building
InstitutionKEMRI-Wellcome Trust Research Programme
AddressKilifi & Nairobi
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Murungi LM, Kamuyu G, Lowe B, Bejon P, Theisen M, Kinyanjui SM, Marsh K, Osier FH. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine. 2013 Aug 20; 31(37):3936-42. PMID: 23800539; PMCID: PMC3763364.
    2. Boga M, Davies A, Kamuya D, Kinyanjui SM, Kivaya E, Kombe F, Lang T, Marsh V, Mbete B, Mlamba A, Molyneux S, Mulupi S, Mwalukore S. Strengthening the informed consent process in international health research through community engagement: The KEMRI-Wellcome Trust Research Programme Experience. PLoS Med. 2011 Sep; 8(9):e1001089. PMID: 21931539; PMCID: PMC3172253.
    3. Muema DK, Ndungu FM, Kinyanjui SM, Berkley JA. Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study. Malar J. 2011 Mar 05; 10:55. PMID: 21375768; PMCID: PMC3066111.
    4. Kinyanjui SM, Bejon P, Osier FH, Bull PC, Marsh K. What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity. Malar J. 2009 Oct 28; 8:242. PMID: 19860926; PMCID: PMC2773787.
    5. Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, Williams TN, Mohammed S, Osier F, Kinyanjui S, Fegan G, Lowe BS, English M, Peshu N, Marsh K, Newton CR. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis. 2009 Aug 01; 49(3):336-43. PMID: 19548833; PMCID: PMC2853703.
    6. Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, Musyoki JN, Bull PC, Marsh K. Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun. 2009 May; 77(5):1917-23. PMID: 19223480; PMCID: PMC2681775.
    7. Whitworth JA, Kokwaro G, Kinyanjui S, Snewin VA, Tanner M, Walport M, Sewankambo N. Strengthening capacity for health research in Africa. Lancet. 2008 Nov 01; 372(9649):1590-3. PMID: 18984193; PMCID: PMC2607030.
    8. Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K. Evidence for over-dispersion in the distribution of clinical malaria episodes in children. PLoS One. 2008 May 21; 3(5):e2196. PMID: 18493319; PMCID: PMC2374912.
    9. Mackintosh CL, Mwangi T, Kinyanjui SM, Mosobo M, Pinches R, Williams TN, Newbold CI, Marsh K. Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children. Int J Parasitol. 2008 Oct; 38(12):1445-54. PMID: 18534600; PMCID: PMC2697313.
    10. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J. 2007 Jun 28; 6:82. PMID: 17598897; PMCID: PMC1920526.
    11. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006 Jan-Feb; 28(1-2):51-60. PMID: 16438676.
      View in: PubMed
    12. Bull PC, Pain A, Ndungu FM, Kinyanjui SM, Roberts DJ, Newbold CI, Marsh K. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. J Infect Dis. 2005 Sep 15; 192(6):1119-26. PMID: 16107968.
      View in: PubMed
    13. Pokhariyal GP, Moturi CA, Hassanali J, Kinyanjui SM. Simulation model for dental arch shapes. East Afr Med J. 2004 Nov; 81(11):599-602. PMID: 15868971.
      View in: PubMed
    14. Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections. J Infect Dis. 2004 Nov 01; 190(9):1527-33. PMID: 15478055.
      View in: PubMed
    15. Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S. Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature. 2004 Jun 03; 429(6991):555-8. PMID: 15175751.
      View in: PubMed
    16. Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K. The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes. J Immunol Methods. 2004 May; 288(1-2):9-18. PMID: 15183081.
      View in: PubMed
    17. Kinyanjui SM, Bull P, Newbold CI, Marsh K. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis. 2003 Feb 15; 187(4):667-74. PMID: 12599084.
      View in: PubMed
    18. Urban BC, Mwangi T, Ross A, Kinyanjui S, Mosobo M, Kai O, Lowe B, Marsh K, Roberts DJ. Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. Blood. 2001 Nov 01; 98(9):2859-61. PMID: 11675362.
      View in: PubMed
    19. Kinyanjui SM, Mberu EK, Winstanley PA, Jacobus DP, Watkins WM. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. Am J Trop Med Hyg. 1999 Jun; 60(6):943-7. PMID: 10403325.
      View in: PubMed
    20. Connelly MP, Fabiano E, Patel IH, Kinyanjui SM, Mberu EK, Watkins WM. Antimalarial activity in crude extracts of Malawian medicinal plants. Ann Trop Med Parasitol. 1996 Dec; 90(6):597-602. PMID: 9039271.
      View in: PubMed
    Kinyanjui's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description